
News
Home>News & Events>Publications>HD-RSC>Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials
376
Related Posts
-
C-Path Appoints Key Scientific Leaders to Executive Roles
-
Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials
-
Volumetric MRI-Based Biomarkers in Huntington’s Disease: An Evidentiary Review
-
New Collaboration Seeks to Speed Huntington’s Disease Drug Licensing